USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ION CHANNEL INNOVATIONS, LLC
Address:
969 PARK AVENUE
NEW YORK, NY 10028-
Phone:
N/A
URL:
N/A
EIN:
174297976
DUNS:
90704540
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,188,748.00 2
SBIR Phase II $1,574,906.00 2

Award List:

Gene transfer to treat urinary urgency, frequency, nocturia and incontinence

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$1,032,812.00
Agency:
HHS
Principal Investigator:
Moses Tar – 718-430-3201
Abstract:
DESCRIPTION (provided by applicant): This grant application is initiated by Ion Channel Innovations, LLC., (ICI) an early stage biotechnology company that has completed the first, and only, phase I safety trial using plasmid DNA transfer with a non-specific gene MaxiK potassium channel promoter to… More

Gene transfer to treat urinary urgency frequency nocturia and incontinence

Award Year / Program / Phase:
2012 / SBIR / Phase II
Award Amount:
$507,071.00
Agency:
HHS
Principal Investigator:
Moses Tar – 718-430-3201
Abstract:
DESCRIPTION (provided by applicant): This grant application is initiated by Ion Channel Innovations, LLC., (ICI) an early stage biotechnology company that has completed the first, and only, phase I safety trial using plasmid DNA transfer with a non-specific gene MaxiK potassium channel promoter to… More

Development of hMaxiK bladder wall injection for overactive bladder treatment

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$155,936.00
Agency:
HHS
Principal Investigator:
Sharon G. Jacobs – 718-430-3201
Abstract:
DESCRIPTION (provided by applicant): This grant application is by Ion Channel Innovations, LLC, (ICI) a company dedicated to the development of naked DNA transfer to treat the unmet needs of people with common smooth muscle diseases that negatively impactthe quality of life of millions. Overactive… More

Development of hMaxiK bladder wall injection for overactive bladder treatment

Award Year / Program / Phase:
2013 / SBIR / Phase II
Award Amount:
$1,067,835.00
Agency:
HHS
Principal Investigator:
Sharon G. Jacobs – 718-430-3201
Abstract:
DESCRIPTION (provided by applicant): This grant application is by Ion Channel Innovations, LLC, (ICI) a company dedicated to the development of naked DNA transfer to treat the unmet needs of people with common smooth muscle diseases that negatively impactthe quality of life of millions. Overactive… More